Literature DB >> 307580

Anti-tumor immunity in B lymphocyte-deprived mice. I. Immunity to a chemically induced tumor.

P Brodt, J Gordon.   

Abstract

Immunity to a syngeneic methylcholanthrene-induced tumor was studied in (C57BL/6 X C3H)F1 males, treated continuously from birth with a rabbit anti-mouse IgM serum. Such mice have been shown to be selectively depleted of Ig-bearing lymphocytes and incapable of synthesizing antibodies. In the experiments reported, a heightened resistance of these mice to the syngeneic fibrosarcoma was demonstrated. This resistance was manifest in significantly slower tumor growth at the site of injection, as well as a lower incidence of spontaneous pulmonary metastasis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 307580

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  Promotion of tumor invasion by cooperation of granulocytes and macrophages activated by anti-tumor antibodies.

Authors:  E Barbera-Guillem; K F May; J K Nyhus; M B Nelson
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

2.  Secretory IgM Exacerbates Tumor Progression by Inducing Accumulations of MDSCs in Mice.

Authors:  Chih-Hang Tang; Shiun Chang; Ayumi Hashimoto; Yi-Ju Chen; Chang Won Kang; Anthony R Mato; Juan R Del Valle; Dmitry I Gabrilovich; Chih-Chi Hu
Journal:  Cancer Immunol Res       Date:  2018-04-12       Impact factor: 11.151

3.  Immunosuppressive and Prometastatic Functions of Myeloid-Derived Suppressive Cells Rely upon Education from Tumor-Associated B Cells.

Authors:  Monica Bodogai; Kanako Moritoh; Catalina Lee-Chang; Christine M Hollander; Cheryl A Sherman-Baust; Robert P Wersto; Yoshihiko Araki; Ichiro Miyoshi; Li Yang; Giorgio Trinchieri; Arya Biragyn
Journal:  Cancer Res       Date:  2015-07-16       Impact factor: 12.701

4.  TGF-βR inhibitor SB431542 restores immune suppression induced by regulatory B-T cell axis and decreases tumour burden in murine fibrosarcoma.

Authors:  Kavitha Premkumar; Bhavani S Shankar
Journal:  Cancer Immunol Immunother       Date:  2020-07-13       Impact factor: 6.968

Review 5.  B lymphocytes and cancer: a love-hate relationship.

Authors:  Grace J Yuen; Ezana Demissie; Shiv Pillai
Journal:  Trends Cancer       Date:  2016-12

6.  Anti-tumor immunoglobulin M increases lung metastasis in an experimental model of malignant melanoma.

Authors:  Nu-man Tsai; Bing-Mae Chen; Shao-Lun Wei; Cheng-Wen Wu; Steve R Roffler
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

7.  Tumor infiltrating CD19+ B lymphocytes predict prognostic and therapeutic benefits in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors.

Authors:  Zhiyuan Lin; Li Liu; Yu Xia; Xiang Chen; Ying Xiong; Yang Qu; Jiajun Wang; Qi Bai; Jianming Guo; Jiejie Xu
Journal:  Oncoimmunology       Date:  2018-08-06       Impact factor: 8.110

8.  Anesthetic drugs accelerate the progression of postoperative metastases of mouse tumors.

Authors:  J Shapiro; J Jersky; S Katzav; M Feldman; S Segal
Journal:  J Clin Invest       Date:  1981-09       Impact factor: 14.808

9.  Natural resistance mechanisms may play a role in protection against chemical carcinogenesis.

Authors:  P Brodt; J Gordon
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

10.  Liver metastases induce reversible hepatic B cell dysfunction mediated by Gr-1+CD11b+ myeloid cells.

Authors:  Mitchell Thorn; Gary R Point; Rachel A Burga; Cang T Nguyen; N Joseph Espat; Steven C Katz
Journal:  J Leukoc Biol       Date:  2014-08-01       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.